Annual Accounts Payable
$2.74 M
-$2.71 M-49.74%
December 31, 2023
Summary
- As of February 8, 2025, IPSC annual accounts payable is $2.74 million, with the most recent change of -$2.71 million (-49.74%) on December 31, 2023.
- During the last 3 years, IPSC annual accounts payable has fallen by -$5.34 million (-66.09%).
- IPSC annual accounts payable is now -66.09% below its all-time high of $8.08 million, reached on December 31, 2020.
Performance
IPSC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.60 M
-$760.00 K-22.63%
September 30, 2024
Summary
- As of February 8, 2025, IPSC quarterly accounts payable is $2.60 million, with the most recent change of -$760.00 thousand (-22.63%) on September 30, 2024.
- Over the past year, IPSC quarterly accounts payable has dropped by -$3.33 million (-56.17%).
- IPSC quarterly accounts payable is now -80.65% below its all-time high of $13.43 million, reached on June 30, 2021.
Performance
IPSC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IPSC Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.7% | -56.2% |
| 3 y3 years | -66.1% | -28.3% |
| 5 y5 years | +77.1% | -28.3% |
IPSC Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.9% | at low | -73.7% | at low |
| 5 y | 5-year | -66.1% | +77.1% | -80.7% | at low |
| alltime | all time | -66.1% | +77.1% | -80.7% | at low |
Century Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.60 M(-22.6%) |
| Jun 2024 | - | $3.36 M(-2.2%) |
| Mar 2024 | - | $3.43 M(+25.2%) |
| Dec 2023 | $2.74 M(-49.7%) | $2.74 M(-53.8%) |
| Sep 2023 | - | $5.93 M(+63.5%) |
| Jun 2023 | - | $3.63 M(+4.3%) |
| Mar 2023 | - | $3.48 M(-36.3%) |
| Dec 2022 | $5.45 M | $5.45 M(-4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.68 M(+40.4%) |
| Jun 2022 | - | $4.05 M(-59.1%) |
| Mar 2022 | - | $9.89 M(+30.2%) |
| Dec 2021 | $7.60 M(-6.0%) | $7.60 M(-34.8%) |
| Sep 2021 | - | $11.64 M(-13.3%) |
| Jun 2021 | - | $13.43 M(+52.3%) |
| Mar 2021 | - | $8.82 M(+9.1%) |
| Dec 2020 | $8.08 M(+422.1%) | $8.08 M |
| Dec 2019 | $1.55 M | - |
FAQ
- What is Century Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Century Therapeutics?
- What is Century Therapeutics annual accounts payable year-on-year change?
- What is Century Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Century Therapeutics?
- What is Century Therapeutics quarterly accounts payable year-on-year change?
What is Century Therapeutics annual accounts payable?
The current annual accounts payable of IPSC is $2.74 M
What is the all time high annual accounts payable for Century Therapeutics?
Century Therapeutics all-time high annual accounts payable is $8.08 M
What is Century Therapeutics annual accounts payable year-on-year change?
Over the past year, IPSC annual accounts payable has changed by -$2.71 M (-49.74%)
What is Century Therapeutics quarterly accounts payable?
The current quarterly accounts payable of IPSC is $2.60 M
What is the all time high quarterly accounts payable for Century Therapeutics?
Century Therapeutics all-time high quarterly accounts payable is $13.43 M
What is Century Therapeutics quarterly accounts payable year-on-year change?
Over the past year, IPSC quarterly accounts payable has changed by -$3.33 M (-56.17%)